🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Huge congratulations to Vincent for his co-first author paper just published in Molecular & Cellular Proteomics!! 🥳🥳🥂This was a wonderful collaborative effort spearheaded by Niclas Karlsson and team to understand lubricin in osteoarthritis! #glycotime sciencedirect.com/science/articl…

Excited to welcome new CMO Dr. Chin Lee to the team Lycia Therapeutics, advancing clinical programs for CataLYTAC IgE degrader to treat allergic conditions, as well as LYTAC degrader of anti-TSHR autoantibodies for treatment of Graves' disease.

#DYK activated memory B cells play a major role in autoimmune diseases, but resist antibody depletion therapies due to high sialylation? Palleon’s E-602 enzymatically removes these sialoglycans, boosting B cell-targeted antibody effectiveness. Learn more: bit.ly/3DUGdvt

Excited to share this new work led by postdoc Brendan Floyd, deep mapping of cell-surface protein interactomes of T and B cells reveals maverick mitochondrial proteins and immune modulatory interactions. biorxiv.org/content/10.110…

Excited to share our new study in nature! We uncover how the vascular glycocalyx—a carbohydrate-rich coating on blood vessels—plays a crucial role in brain health and aging. A Tony Wyss-Coray & Carolyn Bertozzi labs collaboration. 🍭🧠 #glycotime (1/12) nature.com/articles/s4158…

Very excited to announce that I have moved across the pond to start my new position as Assistant Director for Chemoproteomics @ the Nucleus Sarafan ChEM-H. This position allows me to do what I love: fun science, collaborations & teaching everyone about the wonders of #masspec 🥳

New findings from team led by Sophia Shi, Carolyn Bertozzi & Tony Wyss-Coray suggest that changes in the sugar coating on the blood-brain barrier may contribute to age-related cognitive decline and brain disease: stanford.io/4ktHvSb

Remember The Glycans: Consideration of Glycans in Evaluating the Threat of Mirror-Image Life Forms science.org/doi/10.1126/sc… by 32 #glycobiology PIs Laura Kiessling Carolyn Bertozzi GlyCosmos Peter Seeberger Daniel Bojar Prof. Ten Feizi Todd L. Lowary SJ Williams et al #RememberTheGlycans

.Polly Fordyce researchers explore what makes some transcription factors more or less selective for their DNA ligands. This work could guide design of more selective DNA-binding proteins for many bioengineering applications: go.nature.com/4hXnEc5

Tumor glycosylation: a main player in the modulation of immune responses tinyurl.com/4um393yc #glucotime

ICYMI: At AACR IO, Jessica Stark & Gabriel Rabinovich explored the emerging field of #glycoimmunology, highlighting the immunological role of glycans & the potential to target glyco-immune checkpoints in cancer treatment. Read about it here: bit.ly/4itjfgZ #AACRIO #glycotime

At Lycia, we’re pioneering a new approach to treating previously undruggable diseases. If you’re passionate about pushing the boundaries of science, we’re hiring! Check out our job openings: jobs.lever.co/LyciaTherapeut… #LifeAtLycia #BiotechCareers

Self-pigmenting textiles grown from cellulose-producing bacteria with engineered tyrosinase expression | Nature Biotechnology nature.com/articles/s4158…

#Cancer research needs #neuroscience and neuroscientists. Sharing some thoughts on #CancerNeuroscience, together with Frank Winkler. nature.com/articles/s4159…

The Chow Lab is hiring postdocs! We discover modifier genes & therapeutics for rare diseases. Lots of opportunities to work w/ clinicians, families, foundations, & industry. Check out posters: 444, 445, 496, 517, and 519. Also talk 154 on Saturday #Dros25 linktr.ee/clementchow

Exciting new work from Sarafan ChEM-H Institute Scholar Stanley Qi Lab, delivery of biomolecules to cells via trogocytosis 😎

Check out our new review on induced proximity modalities (#TPD and a lot more!) aimed cell surface targets @naturebiotech.bsky.social, spearheaded by postdocs Nick Till and Rahm Ramanathan MD, PhD nature.com/articles/s4158…

Cell surface sugars could unlock safer, more effective autoimmune treatments. Learn more in our Q&A with Li Peng, our CSO, on the science behind our lead drug candidate E-602, which will be evaluated in a Phase 2 trial for #lupusnephritis. bit.ly/4jnahm6 #glycotime

🚨New preprint alert!! Introducing "GlycoFASP" - a super easy method to isolate pure O-glycopeptides from complex samples. Pioneered by Shane and Keira E Mahoney, they show that you can simply add sample + glycoprotease to a MWCO filter -> O-glycopeptides 10.26434/chemrxiv-2025-bxv0k

How can we enable new biomanufacturing practice to support the economy? Vayu Hill-Maini Jennbrophy.bsky.social news.stanford.edu/stories/2025/0…